Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Seki, Tomohisa ^a,b   Yuasa, Shinsuke ^a   Kusumoto, Dai ^a   Kunitomi, Akira ^a   Saito, Yuki ^a   Tohyama, Shugo ^a,b   Yae, Kojiro ^a   Kishino, Yoshikazu ^a   Okada, Marina ^a   Hashimoto, Hisayuki ^a   Takei, Makoto ^a   Egashira, Toru ^a   Kodaira, Masaki ^a   Kuroda, Yusuke ^a   Tanaka, Atsushi ^a   Okata, Shinichiro ^a   Suzuki, Tomoyuki ^a   Murata, Mitsushige ^a   Fujita, Jun ^a   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYURY PROTEIN; ION CHANNEL; MEF2C PROTEIN; MESP1 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ALPHAMHC GENE; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE REARRANGEMENT; HEART CELL CULTURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MLC2V GENE; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL GENE; T CELL DERIVED INDUCED PLURIPOTENT STEM CELL; TCR GENE; WAVEFORM;

ACTION POTENTIALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ION CHANNEL GATING; ION CHANNELS; MYOCYTES, CARDIAC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 84908105780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085645     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209.
2. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
3. Bellin M, Marchetto MC, Gage FH, Mummery CL (2012) Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13: 713-726.
4. Yuasa S, Fukuda K (2008) Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era. Expert Rev Cardiovasc Ther 6: 803-810.
5. Choi SH, Jung SY, Kwon SM, Baek SH (2012) Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. Circ J 76: 1307-1312.
6. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-41.
7. Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, et al. (2009) In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 385: 497-502.
8. Malan D, Friedrichs S, Fleischmann BK, Sasse P (2011) Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ Res 109: 841-847.
9. Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, et al. (2012) Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation. J Cell Mol Med 16: 468-482.
10. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, et al. (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363: 1397-1409.
11. Ma D, Wei H, Lu J, Ho S, Zhang G, et al. (2013) Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 34: 1122-1133.
12. Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, et al. (2011) Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471: 230-234.
13. Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, et al. (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4: 130ra147.
14. Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, et al. (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12: 101-113.
15. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, et al. (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465: 808-812.
16. Zwi-Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, et al. (2013) Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Eur Heart J 34: 1575-1586.
17. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, et al. (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126: S29-37.
18. Sinnecker D, Goedel A, Laugwitz KL, Moretti A (2013) Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research. Circ Res 112: 961-968.
19. Knollmann BC (2013) Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res 112: 969-976; discussion 976.
20. Egashira T, Yuasa S, Fukuda K (2013) Novel insights into disease modeling using induced pluripotent stem cells. Biol Pharm Bull 36: 182-188.
21. Gonzalez F, Boue S, Izpisua Belmonte JC (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12: 231-242.
22. Yamanaka S (2010) Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell 7: 1-2.
23. Seki T, Yuasa S, Oda M, Egashira T, Yae K, et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7: 11-14.
24. Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, et al. (2012) Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 95: 419-429.
25. Suemori H, Yasuchika K, Hasegawa K, Fujioka T, Tsuneyoshi N, et al. (2006) Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 345: 926-932. (Pubitemid 43776486)
26. Conner DA (2001) Mouse embryo fibroblast (MEF) feeder cell preparation. Curr Protoc Mol Biol Chapter 23: Unit 23 22.
27. Tran TH, Wang X, Browne C, Zhang Y, Schinke M, et al. (2009) Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells 27: 1869-1878.
28. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407-414. (Pubitemid 32730787)
29. Smyth JW, Shaw RM (2012) The gap junction life cycle. Heart Rhythm 9: 151-153.
30. Schaub MC, Hefti MA, Zaugg M (2006) Integration of calcium with the signaling network in cardiac myocytes. J Mol Cell Cardiol 41: 183-214. (Pubitemid 44080211)
31. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, et al. (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120: 1513-1523.
32. Germanguz I, Sedan O, Zeevi-Levin N, Shtrichman R, Barak E, et al. (2011) Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 15: 38-51.
33. Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, et al. (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A 109: 12538-12543.
34. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, et al. (2010) Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7: 20-24.
35. Loh YH, Hartung O, Li H, Guo C, Sahalie JM, et al. (2010) Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7: 15-19.
36. Kunisato A, Wakatsuki M, Shinba H, Ota T, Ishida I, et al. (2011) Direct generation of induced pluripotent stem cells from human nonmobilized blood. Stem Cells Dev 20: 159-168.
37. Brown ME, Rondon E, Rajesh D, Mack A, Lewis R, et al. (2010) Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 5: e11373.
38. Hochedlinger K, Jaenisch R (2002) Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415: 1035-1038. (Pubitemid 34193452)
39. Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, et al. (2002) Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200: 233-242. (Pubitemid 34467315)
40. Nakatsuji N, Nakajima F, Tokunaga K (2008) HLA-haplotype banking and iPS cells. Nat Biotechnol 26: 739-740. (Pubitemid 351961440)